# Vera Therapeutics, Inc. (VERA) MD&A by fiscal year

Verbatim Item 7 Management's Discussion and Analysis sections from Vera Therapeutics, Inc.'s 10-K filings, one page per fiscal year. Extracted from SEC filings with the same bounded parser for every year. Filer text, not grepcent analysis or investment advice.

- [FY 2025 MD&A](/company/VERA/mda/fy2025/): filed 2026-02-26; accession 0001193125-26-077442 (https://www.sec.gov/Archives/edgar/data/1831828/000119312526077442/vera-20251231.htm); latest 10-K
- [FY 2024 MD&A](/company/VERA/mda/fy2024/): filed 2025-02-28; accession 0000950170-25-029969 (https://www.sec.gov/Archives/edgar/data/1831828/000095017025029969/vera-20241231.htm)
- [FY 2023 MD&A](/company/VERA/mda/fy2023/): filed 2024-03-27; accession 0000950170-24-036729 (https://www.sec.gov/Archives/edgar/data/1831828/000095017024036729/vera-20231231.htm)
- [FY 2022 MD&A](/company/VERA/mda/fy2022/): filed 2023-03-28; accession 0000950170-23-010288 (https://www.sec.gov/Archives/edgar/data/1831828/000095017023010288/vera-20221231.htm)
- [FY 2021 MD&A](/company/VERA/mda/fy2021/): filed 2022-03-28; accession 0000950170-22-004701 (https://www.sec.gov/Archives/edgar/data/1831828/000095017022004701/vera-20211231.htm)

Back to /company/VERA/